7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)

C166H198F4N30O5 — CID 158500529

IUPAC7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)
SMILESCc1cc(F)cc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1.Cc1cc(F)cc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC5CC(C4)O5)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCC(N5CCC(F)(F)C5)CC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCNCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4C[C@H]5C[C@@H]4CO5)cc23)c1C
InChIInChI=1S/C28H35F2N5.2C24H28N4O.C23H29N5.C23H28N4O.2C22H25FN4O/c1-18-6-5-7-24(19(18)2)20(3)31-27-26-16-23(8-9-25(26)21(4)32-33-27)34-13-10-22(11-14-34)35-15-12-28(29,30)17-35;1-14-6-5-7-21(15(14)2)16(3)25-24-23-11-18(8-9-22(23)17(4)26-27-24)28-12-20-10-19(28)13-29-20;1-14-6-5-7-21(15(14)2)16(3)25-24-23-10-18(8-9-22(23)17(4)26-27-24)28-12-19-11-20(13-28)29-19;1-15-6-5-7-20(16(15)2)17(3)25-23-22-14-19(28-12-10-24-11-13-28)8-9-21(22)18(4)26-27-23;1-15-6-5-7-20(16(15)2)17(3)24-23-22-14-19(27-10-12-28-13-11-27)8-9-21(22)18(4)25-26-23;2*1-14-10-17(12-18(23)11-14)15(2)24-22-21-13-19(27-6-8-28-9-7-27)4-5-20(21)16(3)25-26-22/h5-9,16,20,22H,10-15,17H2,1-4H3,(H,31,33);5-9,11,16,19-20H,10,12-13H2,1-4H3,(H,25,27);5-10,16,19-20H,11-13H2,1-4H3,(H,25,27);5-9,14,17,24H,10-13H2,1-4H3,(H,25,27);5-9,14,17H,10-13H2,1-4H3,(H,24,26);2*4-5,10-13,15H,6-9H2,1-3H3,(H,24,26)/t20-;16-,19-,20-;16-,19?,20?;2*17-;2*15-/m1111111/s1
InChIKeyHJVIJYIQMHQYHF-WFTRIADVSA-N
MW2769.61 g/mol
LogP32.94
Rot. Bonds29

About 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)

7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine) (PubChem CID 158500529) has the molecular formula C166H198F4N30O5 and a molecular weight of 2769.61 g/mol. Its IUPAC name is 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine).

Molecular Properties

Compound Name7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)
PubChem CID158500529
Molecular FormulaC166H198F4N30O5
Molecular Weight2769.61 g/mol
Exact Mass2767.61
IUPAC Name7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)
SMILESCc1cc(F)cc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1.Cc1cc(F)cc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC5CC(C4)O5)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCC(N5CCC(F)(F)C5)CC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCNCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4C[C@H]5C[C@@H]4CO5)cc23)c1C
InChIInChI=1S/C28H35F2N5.2C24H28N4O.C23H29N5.C23H28N4O.2C22H25FN4O/c1-18-6-5-7-24(19(18)2)20(3)31-27-26-16-23(8-9-25(26)21(4)32-33-27)34-13-10-22(11-14-34)35-15-12-28(29,30)17-35;1-14-6-5-7-21(15(14)2)16(3)25-24-23-11-18(8-9-22(23)17(4)26-27-24)28-12-20-10-19(28)13-29-20;1-14-6-5-7-21(15(14)2)16(3)25-24-23-10-18(8-9-22(23)17(4)26-27-24)28-12-19-11-20(13-28)29-19;1-15-6-5-7-20(16(15)2)17(3)25-23-22-14-19(28-12-10-24-11-13-28)8-9-21(22)18(4)26-27-23;1-15-6-5-7-20(16(15)2)17(3)24-23-22-14-19(27-10-12-28-13-11-27)8-9-21(22)18(4)25-26-23;2*1-14-10-17(12-18(23)11-14)15(2)24-22-21-13-19(27-6-8-28-9-7-27)4-5-20(21)16(3)25-26-22/h5-9,16,20,22H,10-15,17H2,1-4H3,(H,31,33);5-9,11,16,19-20H,10,12-13H2,1-4H3,(H,25,27);5-10,16,19-20H,11-13H2,1-4H3,(H,25,27);5-9,14,17,24H,10-13H2,1-4H3,(H,25,27);5-9,14,17H,10-13H2,1-4H3,(H,24,26);2*4-5,10-13,15H,6-9H2,1-3H3,(H,24,26)/t20-;16-,19-,20-;16-,19?,20?;2*17-;2*15-/m1111111/s1
InChIKeyHJVIJYIQMHQYHF-WFTRIADVSA-N
XLogP32.94
TPSA348.77 Ų
H-Bond Donors8
H-Bond Acceptors35
Rotatable Bonds29
Heavy Atoms205
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002769.61
LogP ≤ 532.94
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1035

Analyze 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)?
The IUPAC name of 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine) (CID 158500529) is 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine).
What is the SMILES notation for 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)?
The canonical SMILES for 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine) is Cc1cc(F)cc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1.Cc1cc(F)cc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC5CC(C4)O5)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCC(N5CCC(F)(F)C5)CC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCNCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4C[C@H]5C[C@@H]4CO5)cc23)c1C.
What is the InChIKey of 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)?
The InChIKey is HJVIJYIQMHQYHF-WFTRIADVSA-N. The full InChI is InChI=1S/C28H35F2N5.2C24H28N4O.C23H29N5.C23H28N4O.2C22H25FN4O/c1-18-6-5-7-24(19(18)2)20(3)31-27-26-16-23(8-9-25(26)21(4)32-33-27)34-13-10-22(11-14-34)35-15-12-28(29,30)17-35;1-14-6-5-7-21(15(14)2)16(3)25-24-23-11-18(8-9-22(23)17(4)26-27-24)28-12-20-10-19(28)13-29-20;1-14-6-5-7-21(15(14)2)16(3)25-24-23-10-18(8-9-22(23)17(4)26-27-24)28-12-19-11-20(13-28)29-19;1-15-6-5-7-20(16(15)2)17(3)25-23-22-14-19(28-12-10-24-11-13-28)8-9-21(22)18(4)26-27-23;1-15-6-5-7-20(16(15)2)17(3)24-23-22-14-19(27-10-12-28-13-11-27)8-9-21(22)18(4)25-26-23;2*1-14-10-17(12-18(23)11-14)15(2)24-22-21-13-19(27-6-8-28-9-7-27)4-5-20(21)16(3)25-26-22/h5-9,16,20,22H,10-15,17H2,1-4H3,(H,31,33);5-9,11,16,19-20H,10,12-13H2,1-4H3,(H,25,27);5-10,16,19-20H,11-13H2,1-4H3,(H,25,27);5-9,14,17,24H,10-13H2,1-4H3,(H,25,27);5-9,14,17H,10-13H2,1-4H3,(H,24,26);2*4-5,10-13,15H,6-9H2,1-3H3,(H,24,26)/t20-;16-,19-,20-;16-,19?,20?;2*17-;2*15-/m1111111/s1.
What are the key properties of 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine)?
7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine) has a molecular weight of 2769.61 g/mol, XLogP of 32.94, 29 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)phthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperazin-1-ylphthalazin-1-amine;bis(N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine) is sourced from PubChem (CID 158500529), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).